PAVmed Inc., a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, today provided a strategic business update, outlining near-term strategic priorities and resource reallocation. ... Read More >

QIAGEN today announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available for widescale use 18 months after being made available for research.... Read More >

GE HealthCare, a leader in precision care innovation, today announced preliminary unaudited revenue results for the fourth quarter and full year 2022. The Company also issued Organic revenue growth, Adjusted EBIT margin, and Free cash flow conversion guidance for 2023.... Read More >

THERADIAG, a company specializing in in vitro diagnostics of autoimmune diseases and Theranostics, today reported its 2022 annual revenue and its cash position at December 31, 2022.... Read More >

New Horizon Health announced earnings forecast for financial year 2022: total revenue expected to be RMB 766 million, up 260% year-on-year; Bioeasy 2022 expected net profit CNY 110 million to CNY 150 million... Read More >

On January 14, Shenzhen YHLO Biotech Co., Ltd. released the 2022 annual performance forecast. Read More >

Healthcare and life science firms Pierian, Seven Bridges, and UgenTec have been acquired by investment fund Summa Equity for an undisclosed amount and merged to form a new precision medicine company, Velsera.... Read More >

The US Food and Drug Administration recently granted Emergency Use Authorization for Scope Molecular Laboratory's SARS nCoV-2019 Multiplexed Assay for serial COVID-19 testing. ... Read More >

Agilent Technologies Inc. today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company¡¯s high-quality active pharmaceutical ingredie... Read More >

Bioantibody has completed its first round of financing totaling nearly 100 million yuan. This financing was led by Fang Fund and followed by New Industry Investment, Guoqian Venture Investment, Bondshine Capital. Phoenix Tree Capital acted as the exclusive financial advisor.... Read More >